Gregory N Fuller Selected Research

Adenosine (Adenocard)

1/2020

Profiling of patients with glioma reveals the dominant immunosuppressive axis is refractory to immune function restoration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gregory N Fuller Research Topics

Disease

85	Neoplasms (Cancer) 02/2022 - 01/2002
63	Glioma (Gliomas) 01/2022 - 01/2002
34	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2002
8	Astrocytoma (Pilocytic Astrocytoma) 03/2019 - 01/2002
7	Carcinogenesis 01/2020 - 12/2008
7	Brain Neoplasms (Brain Tumor) 11/2017 - 03/2002
6	Medulloblastoma 01/2021 - 03/2002
6	Breast Neoplasms (Breast Cancer) 01/2019 - 03/2004
6	Neoplasm Metastasis (Metastasis) 09/2018 - 03/2004
6	Melanoma (Melanoma, Malignant) 07/2012 - 11/2003
5	Necrosis 09/2018 - 07/2002
5	Oligodendroglioma 11/2011 - 01/2002
4	Disease Progression 01/2022 - 07/2003
3	Ganglioneuroma 01/2020 - 06/2002
3	Neurocytoma 01/2016 - 01/2004
3	Hypoxia (Hypoxemia) 01/2016 - 07/2002
3	Infections 12/2014 - 10/2003
2	Gliosis 01/2020 - 10/2002
2	Renal Cell Carcinoma (Grawitz Tumor) 10/2018 - 09/2018
2	von Hippel-Lindau Disease (von Hippel Lindau Disease) 10/2018 - 05/2018
2	Chordoma 03/2018 - 10/2016
2	Adenoma (Adenomas) 05/2010 - 02/2005
2	Paraganglioma (Paragangliomas) 05/2008 - 01/2004
2	Cysts 01/2008 - 11/2005
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 06/2005 - 09/2004
1	Choroid Plexus Carcinoma 02/2022
1	Choroid Plexus Neoplasms (Choroid Plexus Tumor) 02/2022
1	Choroid Plexus Papilloma 02/2022

Drug/Important Bio-Agent (IBA)

29	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2002
12	Insulin-Like Growth Factor Binding Protein 2IBA 01/2016 - 01/2002
10	Biomarkers (Surrogate Marker)IBA 06/2019 - 01/2009
7	MicroRNAs (MicroRNA)IBA 12/2018 - 02/2013
7	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 05/2016 - 12/2008
7	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 05/2015 - 07/2007
6	RNA (Ribonucleic Acid)IBA 01/2022 - 02/2013
6	Biological ProductsIBA 10/2019 - 12/2002
6	Platelet-Derived Growth FactorIBA 05/2015 - 04/2005
5	WP1066IBA 01/2022 - 09/2008
5	Therapeutic UsesIBA 01/2020 - 07/2013
5	AntigensIBA 01/2020 - 06/2007
5	Messenger RNA (mRNA)IBA 12/2018 - 01/2004
4	Phosphotransferases (Kinase)IBA 06/2019 - 09/2004
4	IntegrinsIBA 01/2019 - 05/2003
4	Transcription Factors (Transcription Factor)IBA 03/2018 - 03/2002
4	ParaffinIBA 03/2018 - 12/2002
4	Hematoxylin (Haematoxylon)IBA 11/2017 - 05/2015
4	Eosine Yellowish-(YS) (Eosin)IBA 11/2017 - 05/2015
4	Protein Isoforms (Isoforms)IBA 05/2015 - 05/2005
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2014 - 03/2002
4	Complementary DNA (cDNA)IBA 05/2006 - 01/2002
3	Temozolomide (Temodar)FDA LinkGeneric 01/2020 - 01/2019
3	Pharmaceutical PreparationsIBA 12/2018 - 07/2006
3	ChromatinIBA 11/2018 - 11/2011
3	Carrier Proteins (Binding Protein)IBA 11/2018 - 01/2002
3	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2016 - 08/2012
3	Histones (Histone)IBA 05/2015 - 11/2011
3	Insulin-Like Growth Factor Binding ProteinsIBA 02/2012 - 05/2006
3	Hormones (Hormone)IBA 01/2009 - 02/2005
2	Programmed Cell Death 1 ReceptorIBA 01/2020 - 10/2016
2	CytokinesIBA 01/2020 - 12/2014
2	ChemokinesIBA 01/2019 - 12/2014
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2018 - 05/2008
2	Formaldehyde (Formol)FDA Link 03/2018 - 11/2003
2	Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA 01/2018 - 01/2004
2	SurvivinIBA 02/2017 - 09/2014
2	TensinsIBA 10/2016 - 08/2004
2	ErbB Receptors (EGF Receptor)IBA 10/2016 - 08/2004
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 10/2016 - 08/2004
2	Glial Fibrillary Acidic ProteinIBA 01/2016 - 10/2002
2	Progesterone Receptors (Progesterone Receptor)IBA 01/2016 - 05/2008
2	S100 Proteins (S 100 Protein)IBA 01/2016 - 05/2010
2	Cyclin D1IBA 05/2015 - 03/2004
2	LigandsIBA 01/2011 - 07/2010
2	NestinIBA 12/2010 - 10/2002
2	Fibronectins (Fibronectin)IBA 07/2010 - 03/2004
2	Integrin alpha5IBA 07/2010 - 05/2006
2	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2009 - 01/2009
2	Estrogen ReceptorsIBA 05/2008 - 01/2008
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2006 - 03/2002
2	CollagenIBA 12/2006 - 07/2004
2	Retinoblastoma ProteinIBA 05/2006 - 05/2003
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2004 - 07/2002
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 02/2022
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 02/2022
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 02/2022
1	Irinotecan (Camptosar)FDA LinkGeneric 01/2020
1	CateninsIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Adenosine (Adenocard)FDA LinkGeneric 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 01/2020
1	alpha-hydroxyglutarateIBA 01/2020
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2020
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2020

Therapy/Procedure

26	Therapeutics 01/2021 - 01/2002
11	Radiotherapy 02/2022 - 01/2003
9	Drug Therapy (Chemotherapy) 02/2022 - 01/2002
4	Immunotherapy 01/2020 - 06/2007
1	Adjuvant Chemotherapy 02/2022
1	Intravenous Administration 01/2020
1	Second-Look Surgery 01/2020